Key Takeaways
- Albemarle delivered Q1 EPS of $2.95, significantly surpassing Wall Street’s $1.19 forecast
- First-quarter revenue reached $1.4 billion, marking a 33% increase from $1.1 billion year-over-year
- ALB shares rallied 11% to $213 during Thursday’s early session
- Current lithium prices hover around $26,000 per metric ton, representing a significant recovery from under $10,000 twelve months prior
- UBS maintained its Buy recommendation with a $230 target price after analyzing the results
Shares of Albemarle rocketed 11% higher to $213 during early Thursday trading following the lithium manufacturer’s first-quarter earnings report that significantly exceeded analyst projections.
The Charlotte-based company announced adjusted earnings per share of $2.95, dramatically outperforming the Street’s consensus forecast of $1.19. First-quarter revenue totaled $1.4 billion, surpassing analyst expectations of $1.3 billion while representing a robust 33% year-over-year increase.
Adjusted EBITDA registered at $664 million — representing a remarkable 50% outperformance versus the $444 million consensus figure. This marks an impressive 148% surge compared to the prior-year period.
In the comparable quarter last year, Albemarle reported a per-share deficit of 18 cents alongside $1.1 billion in revenue. The reversal has been nothing short of dramatic.
The primary catalyst driving these exceptional results is the resurgence in lithium pricing. Industry benchmark prices currently stand at approximately $26,000 per metric ton. A year earlier, these same prices languished below the $10,000 threshold. The market witnessed prices exceeding $85,000 per metric ton during late 2022 before collapsing due to excessive supply combined with weakening electric vehicle demand.
The current price recovery stems from expanding demand in energy storage applications, which has helped restore equilibrium between supply and demand dynamics. Albemarle specifically highlighted increased volumes and improved pricing from energy storage clients.
Impressive Margin Performance, Though Q2 Faces Headwinds
The Energy Storage and lithium business segments achieved margins of approximately 62% during the quarter, substantially exceeding the Street’s 45% consensus projection. Favorable timing in spodumene transactions contributed meaningfully to this outperformance.
Both the Specialties division and Catalyst/Other segments exceeded forecasts by roughly $20 million each. The company reaffirmed its full-year guidance, which incorporates approximately $80 million in supply chain disruption expenses linked to Middle East logistics challenges.
Looking toward the second quarter, management anticipates sequential margin compression attributable to unfavorable spodumene timing dynamics and elevated supply chain costs. The company achieved $17 per LCE during Q1 and projects this metric to improve as the year progresses.
Wall Street Remains Bullish, Annual Projections Strengthen
UBS maintained its Buy stance and $230 price objective on ALB shares following the quarterly disclosure. The firm emphasized that the earnings beat was comprehensive across all operating segments.
Citi analyst Patrick Cunningham highlighted that second-quarter EBITDA should demonstrate sequential improvement in both Energy Storage and Specialties divisions — an observation he characterized as particularly positive for the investment community.
Using Q1’s average lithium pricing as a baseline, Albemarle leadership indicated full-year sales would approximate $5.85 billion with EBITDA reaching roughly $2.5 billion. Current Wall Street models project $5.8 billion in revenue and $2.3 billion in EBITDA for 2026.
The company’s lithium volume guidance remains stable at flat year-over-year levels, despite potential headwinds from reduced production at the Greenbushes mining operation. UBS suggested this outlook could exceed cautious investor expectations if ultimately validated.
Prior to Thursday’s rally, ALB shares closed Wednesday at $193.58, having already appreciated approximately 37% year-to-date in 2026 and skyrocketing 236% over the trailing twelve-month period. The stock previously traded above $325 during late 2022 when lithium commanded peak pricing.
Albemarle generated $3.5 billion in EBITDA during 2022, followed by $1.1 billion in 2025. The first quarter 2026 EBITDA of $664 million positions the company on a substantially improved financial trajectory for the remainder of the fiscal year.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
